In continuation to its earlier intimation dated June 10, 2025, regarding the proposed subscription to the equity shares of Xbrane Biopharma AB, Sweden. In this regard, OneSource Specialty Pharma has informed that it enclosed the press release titled ‘OneSource and Xbrane Biopharma Announce Biosimilars Manufacturing Partnership for the Global Markets.’
The above information is a part of company’s filings submitted to BSE.